Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
From MaRDI portal
Publication:1405284
DOI10.1016/S0025-5564(03)00058-0zbMath1030.92016WikidataQ44495120 ScholiaQ44495120MaRDI QIDQ1405284
Yangxin Huang, Susan L. Rosenkranz, Hulin Wu
Publication date: 25 August 2003
Published in: Mathematical Biosciences (Search for Journal in Brave)
HIVOrdinary differential equationsPharmacokineticsDrug resistanceAdherenceAntiviral therapyClinical trial simulation
Related Items (48)
Impact of antimicrobial usage on the transmission dynamics of antimicrobial resistant bacteria among pigs ⋮ Stability analysis and memetic computation using differential evolution for in-host HIV model ⋮ Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors ⋮ An HIV infection model based on a vectored immunoprophylaxis experiment ⋮ Piecewise HIV virus dynamic model with CD4\(^+\) T cell count-guided therapy: I ⋮ Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide ⋮ Nonlinear and robust control strategy based on chemotherapy to minimize the HIV concentration in blood plasma ⋮ Stabilization of HIV/AIDS model by receding horizon control ⋮ Stochastic HIV model coupled with pharmacokinetics and drug adherence may explain intermittent viral blips ⋮ DYNAMICS OF A NON-AUTONOMOUS HIV-1 INFECTION MODEL WITH DELAYS ⋮ Mathematical analysis of an HIV infection model including quiescent cells and periodic antiviral therapy ⋮ Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay ⋮ Manifold-constrained Gaussian process inference for time-varying parameters in dynamic systems ⋮ Emergence of HIV-1 drug resistance during antiretroviral treatment ⋮ Mathematical analysis of an HIV model with impulsive antiretroviral drug doses ⋮ Mathematical Modeling of HIV-1 Infection and Drug Therapy ⋮ New insights into pharmacologic inhibition of pyroptotic cell death by necrosulfonamide: a PDE model ⋮ A Bayesian approach in differential equation dynamic models incorporating clinical factors and covariates ⋮ Optimal drug treatment regimens for HIV depend on adherence ⋮ Effect of cellular reservoirs and delays on the global dynamics of HIV ⋮ THE DYNAMICS OF HIV MODELS WITH SWITCHING PARAMETERS AND PULSE CONTROL ⋮ Time periodic reaction-diffusion equations for modeling 2-LTR dynamics in HIV-infected patients ⋮ Spatially antiviral dynamics determines HCV in vivo replication and evolution ⋮ Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy ⋮ Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility ⋮ Permanence and extinction of a non-autonomous HIV-1 model with time delays ⋮ Time-varying pharmacodynamics in a simple non-integer HIV infection model ⋮ A within-host virus model with multiple infected stages under time-varying environments ⋮ Parameter identifiability and estimation of HIV/AIDS dynamic models ⋮ A dynamic Bayesian nonlinear mixed-effects model of HIV response incorporating medication adherence, drug resistance and covariates ⋮ A multiscale model on hospital infections coupling macro and micro dynamics ⋮ On the modeling of long-term HIV-1 infection dynamics ⋮ Statistical methods for HIV dynamic studies in AIDS clinical trials ⋮ Oscillatory viral dynamics in a delayed HIV pathogenesis model ⋮ Sieve estimation of constant and time-varying coefficients in nonlinear ordinary differential equation models by considering both numerical error and measurement error ⋮ Comparison of particle swarm and bacterial foraging optimization algorithms for therapy planning in HIV/AIDS patients ⋮ Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy ⋮ Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study ⋮ Viral dynamics of an HIV model with pulse antiretroviral therapy and adherence ⋮ Long-term HIV dynamic models incorporating drug adherence and resistance to treatment for prediction of virological responses ⋮ Threshold dynamics for an HIV model in periodic environments ⋮ Hierarchical Bayesian Methods for Estimation of Parameters in a Longitudinal HIV Dynamic System ⋮ Monte Carlo estimates of natural variation in HIV infection ⋮ Models and estimation methods for clinical HIV-1 data ⋮ A Bayesian approach for estimating antiviral efficacy in HIV dynamic models ⋮ A delay-dependent model with HIV drug resistance during therapy ⋮ A numerical efficient splitting method for the solution of HIV time periodic reaction-diffusion model having spatial heterogeneity ⋮ Machine learning for mathematical models of HCV kinetics during antiviral therapy
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- HIV-1 infection and low steady state viral loads
- Stochastic modeling of the dynamics of \(CD4^ +\) \(T\)-cell infection by HIV and some Monte Carlo studies
- Dynamics of HIV infection of CD4\(^ +\) T cells
- Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models
- Production of resistant HIV mutants during antiretroviral therapy
- Population HIV‐1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials
This page was built for publication: Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity